Skip to main content

Allergy Relief

NDC 54257-270 · Magno-Humphries, Inc.

Generic nameCETIRIZINE HYDROCHLORIDE
Dosage formTABLET
RouteORAL
Active ingredient(s)CETIRIZINE HYDROCHLORIDE
Strength10 mg/1
Pharmacologic classHistamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
Marketing categoryANDA

Packages

54257-270-02 — 100 TABLET in 1 BOTTLE (54257-270-02)

54257-270-05 — 500 TABLET in 1 BOTTLE (54257-270-05)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

51672-2106 — Cetirizine Hydrochloride, 51672-2147 — Cetirizine Hydrochloride, 51672-4070 — Cetirizine Hydrochloride, 51824-104 — Cetirizine HCl, 53209-5001 — Cetirizine Hydrochloride, 53329-033 — cetirizine hcl, 53943-130 — Cetirizine Tablets, 53943-194 — Cetirizine hydrochloride, 53943-219 — Cetirizine HCl, 53943-519 — Cetirizine Hydrochloride, 55111-351 — Cetirizine Hydrochloride, 55111-699 — Cetirizine Hydrochloride, 55154-0194 — Cetirizine Hydrochloride, 55154-5399 — cetirizine hydrochloride, 55289-995 — Cetirizine Hydrochloride, 55301-076 — Cetirizine Hydrochloride, 55315-354 — Cetirizine Hydrochloride, 55319-939 — Cetirizine Hydrochloride, 55319-962 — Cetirizine HCl, 55681-073 — CETIRIZINE HYDROCHLORIDE, +411 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels